BioProcess International is part of the Informa Connect Division of Informa PLC

Informa PLC|ABOUT US|INVESTOR RELATIONS|TALENT

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

About Subscribe Contribute

Upstream

Recent in Manufacturing

See all

Monoclonal Antibody Productivity

Single Use

A Fully Single-Use Downstream Process for Monoclonal Antibodies A Fully Single-Use Downstream Process for Monoclonal Antibodies

byShunsuke Shiina, Neha Saxenaand 1 more

Apr 17, 2024

Artificial intelligence

Information Technology

Using Artificial Intelligence for Monoclonal Antibody Discovery Using Artificial Intelligence for Monoclonal Antibody Discovery

byWilliam Whitford

Apr 17, 2024

Analytical

Recent in Therapeutic Modalities

See all

Sino Biological’s Center for Bioprocessing (C4B) in Houston, TX

Emerging Therapeutics

Recombinant Antibody Technology: Its Criticality to Past and Future Biopharmaceutical Success Recombinant Antibody Technology: Its Criticality to Past and Future Biopharmaceutical Success

bySuranjana Sen

Apr 17, 2024

Characterization methodologies

Emerging Therapeutics

Intact and Subunit Molecular Mass Analysis for Development of Antibody Therapeutics: Considerations for Novel Biotherapeutics and Biosimilars Intact and Subunit Molecular Mass Analysis for Development of Antibody Therapeutics: Considerations for Novel Biotherapeutics and Biosimilars

bySanjib Banerjee, Rajiv Bharadwaj

Apr 17, 2024

BioProcess Insider

Recent in BioProcess Insider

See all

thumbnail

Therapeutic Class

Bioprocess industry eyes China's stimulus program amid funding woes Bioprocess industry eyes China's stimulus program amid funding woes

byShreeyashi Ojha

May 1, 2024

2 Min Read

thumbnail

Global Markets

BIOSECURE and Catalent deal could bag more biz for Thermo BIOSECURE and Catalent deal could bag more biz for Thermo

byMillie Nelson

Apr 29, 2024

3 Min Read

Global Markets
Bioprocess Insider
Manufacturing
Webcasts

BioProcess Insider State of the Industry — September 2021 Panel Discussion

BioProcess Insider's Editor in Chief sat down with biopharmaceutical inudstry experts to reflect on how the quarterly movements of the wider pharma industry are affecting the biomanufacturing space

BPI Staff

September 29, 2021

20 Min View

BioProcess Insider State of the Industry — September 2021 Panel Discussion

Date: Sep 29, 2021

Duration: 20 Min

Our BioProcess Insider editorial team sits down with Joshua Speidel, PhD Partner, Latham Biopharm Group, Patrick Lucy, President and CEO, Lykan Biosciences, and Amélie Boulais, Head of Market Entry Strategy, Virus Based Therapeutics at Sartorius, to reflect on how the quarterly movements of the wider pharma industry are affecting the biomanufacturing space. Through the analysis of global events, recent deal making, and regulatory and technological advancements, we look to determine the factors driving or squeezing production and pre-empt upcoming trends and concerns facing our sector.